Research Article
Serum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes
Table 3
Bivariate correlation analysis between study parameters and serum osteoprotegerin levels.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2hPG, 2 h postprandial plasma glucose; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMD, bone mineral density; BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimate glomerular filtration rate; FINS, fasting insulin; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA-B, homeostasis model assessment of β-cell function; LDL-C, low-density lipoproteincholesterol; Ln HOMA-IR, natural logarithmic transformation homeostasis model of assessment for insulin resistance index; OPG, osteoprotegerin; QUICKI, quantitative insulin sensitivity check index; SBP, systolic blood pressure; SDP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; URCA, blood uric acid. |